ESC Premium Access

Introduction - Outcomes of GLP-1 RA in diabetes and cardiovascular disease - Discussing the key opportunities for cardiology practice

Topic: Diabetes and the Heart
Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Novo Nordisk

Congress Presentation

About the speaker

Professor Thomas Felix Luscher

Royal Brompton Hospital Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
46 presentations
3 followers

3 more presentations in this session

Summary - GLP-1 receptor agonists - The cardiovascular benefits beyond glucose control.

Speaker: Professor S. Jacob (Villingen, DE)

Thumbnail

Summary - Translating GLP-1 trial outcomes to cardiology practice - Which patients will benefit?

Speaker: Professor L. Ryden (Stockholm, SE)

Thumbnail

Discussion - GLP-1 RA in diabetes and cardiovascular disease - What are the key opportunities for cardiology practice

Speaker: Professor T. Luscher (London, GB) Professor L. Ryden (Stockholm, SE) Professor S. Jacob (Villingen, DE)

Thumbnail

Access the full session

Outcomes of GLP-1 RA in diabetes and cardiovascular disease - Discussing the key opportunities for cardiology practice

Speakers: Professor T. Luscher, Professor S. Jacob, Professor L. Ryden, Professor T. Luscher, Professor L. Ryden...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb